Skip to Content

Ascorbic Acid Injection

Last Updated: February 6, 2015
Status: Resolved

Products Affected - Description

Ascorbic acid injection, American Regent
500 mg/mL, 50 mL vial (NDC 00517-5050-01)

Reason for the Shortage

  • American Regent has ascorbic acid injection on shortage due to manufacturing delays.
  • Hospira has discontinued all presentations of Cenolate injection and all supplies were depleted as of early-February, 2010.

Available Products

Ascorbic acid injection, Mylan Institutional
500 mg/mL, 50 mL vial (NDC 67457-0118-50)

Estimated Resupply Dates

  • American Regent has ascorbic acid injection on a long term back order and the company cannot estimate a release date.
  • Mylan Institutional has been supplying the market for several months.

Updated

February 6, 2015; November 17, 2014; September 3, 2014; June 2, 2014; February 26, 2014; January 2, 2014; October 28, 2013; August 22, 2013; June 24, 2013; April 29, 2013; February 27, 2013; November 28, 2012; August 21, 2012; June 19, 2012; April 10, 2012; February 3, 2012; December 14, 2011; November 9, 2011; September 28, 2011; August 17, 2011; July 20, 2011; June 23, 2011; May 17, 2011; April 29, 2011; March 24, 2011; February 4, 2011; December 29, 2010; November 24, 2010; October 20, 2010; October 11, 2010; August 16, 2010; June 16, 2010; April 13, 2010; March 17, 2010; February 26, 2010, University of Utah, Drug Information Service. Copyright 2015, Drug Information Service, University of Utah, Salt Lake City, UT.

Hide